These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5081625)

  • 1. Possibility of using an alkylating agent in radiotherapy of mammary carcinoma in C3H-He mice.
    Urano M; Tanaka N; Hayashi S
    Gan; 1972 Aug; 63(4):491-4. PubMed ID: 5081625
    [No Abstract]   [Full Text] [Related]  

  • 2. The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation.
    Grau C; Zachariae C; Mao HS; Overgaard J
    Acta Oncol; 1990; 29(6):769-74. PubMed ID: 2223148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--II. Cyclophosphamide.
    Twentyman PR; Kallman RF; Brown JM
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1425-7. PubMed ID: 536251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental study on the effectiveness of BRM in radiation therapy--OK-432 and cyclophosphamide].
    Norimura T; Kunugita N; Dohi S; Mukae S; Tsuchiya T
    Gan No Rinsho; 1988 Oct; 34(13):1811-5. PubMed ID: 3199515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined effects of radiotherapy and hyperthermia on C3H/He mouse mammary carcinoma].
    Okabe H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Oct; 45(10):1377-85. PubMed ID: 4088847
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiotherapy of a mouse mammary carcinoma following treatment with 5-iodo-2'-deoxyuridine.
    Stone HB
    Radiology; 1974 Sep; 112(3):719-25. PubMed ID: 4843309
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental study of an active specific immunotherapy modified with irradiation. 2. Inhibiton of transplanted MM46-tumor growth in C3H/He mice pretreated with immunotherapy].
    Imanaka K; Ogawa Y; Takashima H; Okuno T; Inomata Y; Ichiyanagi A; Ashida C; Gose K; Oshitani T; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Jun; 17(4):1043-47. PubMed ID: 7130794
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor control by irradiation: A C3H-He mouse mammary carcinoma in mammary-tumor-agent-positive and mammary-tumor-agent-free mice.
    Suit H; Kastelan A
    J Natl Cancer Inst; 1968 May; 40(5):945-50. PubMed ID: 5648138
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy of a solid murine tumor with cyclophosphamide and radiation: the effects of time, dose and assay method.
    Begg AC; Fu KK; Shrieve DC; Phillips TL
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1433-9. PubMed ID: 536253
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Localized irradiation on tumors and immune cell reactions--histoenzymatic evaluation using MM 46 tumor and Ehrlich tumor-bearing C3H/He mice].
    Imanaka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):355-69. PubMed ID: 6866746
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice.
    Costanza ME; Vaage J
    J Natl Cancer Inst; 1983 Mar; 70(3):511-6. PubMed ID: 6572739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide and irradiation with 10 MeV electrons--verification of the therapeutic results with 31P-NMR spectroscopy.
    Ulmer W
    Strahlenther Onkol; 1991 Sep; 167(9):553-60. PubMed ID: 1925940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of singe or multifractionated irradiation with 2 MeV fast neutrons on C3H mouse mammary carcinoma" (author's transl)].
    Tsunemoto H; Kutsutani Y; Koike S; Ando K; Furukawa S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1975; 35(12):1116-24. PubMed ID: 818615
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination therapy of radiation and immunomodulators in the treatment of MM46 tumor transplanted in C3H/He mice].
    Miyaji C; Ogawa Y; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Jun; 17(4):1035-42. PubMed ID: 7130793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dependence of radiosensitizing effect on the temperature of hyperthermia].
    Tsumura M; Nakajima T; Tanaka M; Kida A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Nov; 45(11):1441-54. PubMed ID: 4094881
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor control and pulmonary metastasis in fractionally irradiated transplanted mammary carcinoma in C3H mice.
    Seydel HG; Sloan KW; McCready W
    J Natl Cancer Inst; 1972 Feb; 48(2):357-62. PubMed ID: 4568965
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell kinetics after vincristine treatment of C3H/He spontaneous mammary tumors: implications for therapy.
    Braunschweiger PG; Schiffer LM
    J Natl Cancer Inst; 1978 May; 60(5):1043-8. PubMed ID: 642025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.